Fundraising Fox
/Investors
Sign in

Canica — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Cytovationcytovation.cominJun 2023 · $8M

Cytovation develops immunotherapy treatments designed to enhance immune response against various cancer types, with a focus on engineered synthetic peptides and first-in-class therapeutic candidates.

BiotechHealthtechMedical DevicesBergen, NO

Lars Prestegarden(Co-founder & Chief Executive Officer (CEO))in

Co-investorsSandwater

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.